These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 9488793)

  • 1. Venous thrombo-embolism and hormone replacement therapy.
    Whitehead M; Godfree V
    Baillieres Clin Obstet Gynaecol; 1997 Sep; 11(3):587-99. PubMed ID: 9488793
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Postmenopausal hormone replacement therapy and venous thromboembolism.
    Wu O
    Gend Med; 2005; 2 Suppl A():S18-27. PubMed ID: 16551553
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hormone replacement therapy and venous thromboembolism.
    Eisenberger A; Westhoff C
    J Steroid Biochem Mol Biol; 2014 Jul; 142():76-82. PubMed ID: 24007716
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hormone replacement therapy in women with history of thrombosis or a thrombophilia.
    Morris G; Talaulikar V
    Post Reprod Health; 2023 Mar; 29(1):33-41. PubMed ID: 36573625
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HRT and the risk of deep vein thrombosis.
    Barlow DH
    Int J Gynaecol Obstet; 1997 Oct; 59 Suppl 1():S29-33. PubMed ID: 9386213
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effects of hormone replacement treatment of menopause on the risk of venous thromboembolic disease].
    Thery C; Prat A; Asseman P; Bauchart JJ; Michon P; Lesenne M; Jude B
    Therapie; 1997; 52(3):165-8. PubMed ID: 9366099
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent concerns surrounding HRT.
    Armitage M; Nooney J; Evans S
    Clin Endocrinol (Oxf); 2003 Aug; 59(2):145-55. PubMed ID: 12864790
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of the risk for venous thromboembolism among users of hormone replacement therapy.
    Oger E; Scarabin PY
    Drugs Aging; 1999 Jan; 14(1):55-61. PubMed ID: 10069408
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Hormone replacement therapy and venous thromboembolism].
    Trillot N; Susen S; Jude B
    Gynecol Obstet Fertil; 2004 Sep; 32(9):725-8. PubMed ID: 15380753
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long term hormone therapy for perimenopausal and postmenopausal women.
    Marjoribanks J; Farquhar C; Roberts H; Lethaby A
    Cochrane Database Syst Rev; 2012 Jul; (7):CD004143. PubMed ID: 22786488
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Oral contraception and menopausal hormone replacement: effects on hemostasis and risk of venous thromboembolism].
    Bounameaux H; de Moerloose P; Campana A
    Schweiz Med Wochenschr; 1996 Oct; 126(41):1756-63. PubMed ID: 8966508
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent epidemiological studies of the association between hormone replacement therapy and venous thromboembolism. A review.
    Castellsague J; Pérez Gutthann S; García Rodríguez LA
    Drug Saf; 1998 Feb; 18(2):117-23. PubMed ID: 9512918
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence-based indications for thrombophilia screening.
    Lindhoff-Last E; Luxembourg B
    Vasa; 2008 Feb; 37(1):19-30. PubMed ID: 18512539
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral contraceptives, hormone replacement therapy, thrombophilias and risk of venous thromboembolism: a systematic review. The Thrombosis: Risk and Economic Assessment of Thrombophilia Screening (TREATS) Study.
    Wu O; Robertson L; Langhorne P; Twaddle S; Lowe GD; Clark P; Greaves M; Walker ID; Brenkel I; Regan L; Greer IA
    Thromb Haemost; 2005 Jul; 94(1):17-25. PubMed ID: 16113779
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased risk of recurrent venous thromboembolism during hormone replacement therapy--results of the randomized, double-blind, placebo-controlled estrogen in venous thromboembolism trial (EVTET).
    Høibraaten E; Qvigstad E; Arnesen H; Larsen S; Wickstrøm E; Sandset PM
    Thromb Haemost; 2000 Dec; 84(6):961-7. PubMed ID: 11154141
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neonatal thrombo-embolism: risk factors, clinical features and outcome.
    Demirel N; Aydin M; Zenciroglu A; Bas AY; Yarali N; Okumus N; Cinar G; Ipek MS
    Ann Trop Paediatr; 2009 Dec; 29(4):271-9. PubMed ID: 19941750
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Hormone replacement therapy and venous thromboembolism].
    Pavičić Baldani D; Skrgatić L; Simunić V; Elvedi Gasparović V; Geršak B
    Lijec Vjesn; 2015; 137(1-2):34-40. PubMed ID: 25906547
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Future research needs for venous thrombo-embolic disease in obstetrics and gynaecology.
    Brocklehurst P
    Baillieres Clin Obstet Gynaecol; 1997 Sep; 11(3):601-10. PubMed ID: 9488794
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hormone replacement therapy: dilemmas in 2002.
    Moore A
    Trans Am Clin Climatol Assoc; 2003; 114():233-8; discussion 238-40. PubMed ID: 12813923
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The adverse effects of hormone replacement therapy.
    Tavani A; La Vecchia C
    Drugs Aging; 1999 May; 14(5):347-57. PubMed ID: 10408735
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.